Leah R. Sauter

Leah's experience includes representing:

Public and Strategic Companies

• BBAI Holdings, the NYSE-listed provider of intelligence solutions, in its stock-for-stock acquisition of Pangiam
• Con Edison in its divestiture of its clean energy business to RWE for US$6.8 billion
• CSC in its approximately US$6 billion spin-off of CSRA and special dividend and the approximately US$2.3 billion merger of CSRA and SRA International*
• CyberArk in its US$1.54 billion acquisition of Venafi
• DXC Technology Company in numerous transactions, including the:
  • Divestiture of its US State and Local Health and Human Services business to Veritas Capital for US$5 billion
  • Divestiture of its healthcare provider software business to Dedalus Group for US$525 million
  • US$4.4 billion spin-off and subsequent three-way merger of its US government IT services business with Veritas Capital-owned Vencore and KeyPoint Government Solutions that resulted in the formation of NYSE-listed Perspecta Inc.
  • US$14 billion Reverse Morris Trust transaction involving Hewlett Packard Enterprise Company's global enterprise services segment and Computer Sciences Corporation that resulted in the formation of DXC*
• Harry’s in its proposed US$1.37 billion merger with Edgewell Personal Care
• Homology Medicines in its stock-for-stock reverse merger with Q32 Bio
• Inovalon in its US$7.3 billion take-private sale to an equity consortium led by Nordic Capital
• London Stock Exchange Group in its US$1.1 billion divestiture of BETA+ to Clearlake Capital Group and Motive Partners
• L’Oréal in its acquisition of Youth to the People, a California-based skincare company
• NeoGames in its US$1.2 billion take-private sale to Aristocrat Leisure
• Ribbon Communications in its acquisition of ECI Telecom Group, an Israel-based global provider of ELASTIC network solutions to service providers, critical industries, and data center operators
• Romeo Power in its stock-for-stock merger with Nikola
• The Special Committee of the Board of Directors of NYSE-listed Sculptor Capital Management in connection with its evaluation of strategic alternatives and US$719 million acquisition by Rithm Capital
• Siemens Healthineers AG in its US$16.4 billion acquisition of Varian Medical Systems, Inc.
• Swedish Orphan Biovitrum in its US$1.7 billion acquisition of CTI Biopharma
• Tapestry in its US$8.5 billion acquisition of Capri Holdings
• T-Mobile in its agreement with DISH to divest Sprint’s prepaid businesses and Sprint’s 800 MHz spectrum assets for approximately US$5 billion
• Thomson Reuters Corporation in the:
  • Acquisition of CaseText, a legal technology provider
  • Acquisition of Integration Point, a provider of global trade management software
  • Acquisition of SurePrep, a provider of tax automation software
  • Acquisition of ThoughtTrace, a document-understanding and contract-analysis platform
  • Divestiture of its Intellectual Property & Science segment to Onex and Baring for US$3.55 billion*

Private Equity

• Ardian in its acquisition of a 50% stake in Angus Chemical Company, a manufacturer and distributor of nitroalkane based chemicals
• Astorg Partners in the:
  • Divestitures by portfolio company Clario of its Drug Safety and Pharmacovigilance Services Solutions (DSS) division to Stanley Capital Partners and its Software Solutions business to Sitero
  • Acquisition of Corsearch, a provider of a suite of end-to-end brand risk and performance solutions including trademark research, online brand protection, and anti-piracy, from Audax Private Equity
  • Investment in eResearchTechnology, a leading clinical trial technology and data company, in a deal reported to be valued at US$3.8 billion
  • Acquisition of Anaqua, a provider of intellectual property asset management software and maintenance services, from Insight Venture Partners
• Gurnet Point Capital in the:
  • Take-private acquisition of Radius Health for US$890 million
  • Take-private acquisition of Paratek Pharmaceuticals for US$462 million

Financial Advisor Representation

• Centerview in its role as financial advisor to the:
  • US$10.6 billion acquisition of Oak Street Health by CVS Health
  • US$1.1 billion acquisition of Convey Health by TPG
• Morgan Stanley in its role as financial advisor to the:
  • US$2.7 billion acquisition of AssetMark by GTCR
  • US$5.2 billion acquisition of Atlas Air by an investor consortium led by Apollo, J.F. Lehman & Company, and Hill City Capital

*Matter handled prior to joining Latham